A puzzling case of cryptococcal meningitis by Brown, Stewart James et al.
CORRESPONDENCE
720       November 2014, Vol. 104, No. 11
A puzzling case of cryptococcal 
meningitis
To the Editor: We recently admitted a young immunocompetent 
man with cryptococcal meningitis. He presented alone, and a 
combination of language barrier and blunted cerebral function 
hampered history taking. He described 1 week of headache and 
fever, and gave a vague account of a penetrating head injury 6 
months previously.
It was difficult to explain why this otherwise healthy young man, 
with no evident risk factors for poor T-cell function, had encapsulated 
yeasts growing in his cerebrospinal fluid. Multiple HIV rapid antigen 
tests were negative, and 2 weeks of intravenous amphotericin B and 
oral fluconazole did little to improve his condition.
We were poised to embark on the somewhat lengthy referral 
procedure for a computed tomography brain scan at our tertiary 
centre when our patient noticed a small amount of pus discharging 
from a scar on his scalp. A firm prominence was palpated just under 
the scar, and a subsequent X-ray solved the mystery (Fig. 1).
After surgical removal of the knife blade, the meningitis resolved 
within several days. The patient was then able to give a more detailed 
history, and it transpired that he had not come to hospital after the 
initial injury 6 months earlier because of transport and financial 
constraints.
A retained foreign body is an often-overlooked differential 
diagnosis in patients who present with atypical infection.[1] A good 
history is the single most useful tool in making the diagnosis. This 
has been well described in the context of inhaled objects in the 
paediatric population.[2]
Difficulty in obtaining a complete history can delay diagnosis 
and definitive treatment. Maintaining a high index of suspicion, 
and early use of simple imaging where there is any possibility of 
prior penetrating trauma, may assist in early exclusion of a retained 
foreign body. Making a delayed diagnosis by means of unnecessary 
and expensive investigations at tertiary referral centres can then be 
avoided.
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Fig. 1. Cryptococcal meningitis in an otherwise healthy young man – the 
puzzle solved.
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Diabetes Mellitus (DM) is considered one of the most common chronic diseases worldwide. The prevalence of DM 
(HbA1c > 6.5%) in South Africa is reported to be 9.6%, while 19% of the population has impaired glucose 
homeostasis (6.1% < HbA1c < 6.5%).1
Conclusion
The prevalence of DM in South Africa is
alarmingly high, with nearly 10% of the popu­
lation suffering from the condition. Every 
effort should be made to curb the growth in 
cases effectively. Medical nutrition therapy 
guidelines include being physically active and
following a balanced diet that includes a wide 
variety of foods. As the daily intake of dairy 
products, especially low­fat options, signifi­
cantly reduces the risk of developing DM, 
dairy should be emphasised as part of a 
healthy diet. 
Research shows that poor diet and lifestyle factors (lack of exercise and obesity) seem toplay the biggest role in the development of type 2 DM. Medical nutrition therapy guide­lines recommended for the management of DM includes following a healthy, balancedeating plan, with the optimal combination of macronutrients individualized for carbo­
hydrates and fat2. It is advised that a variety of protein sources be consumed, which is associated
with a reduction in the intake of red meat3,4 and a concomitant increase in the intake of nuts and
low­fat dairy products.1,2,5
The role of dairy consumption in DM has received considerable attention lately. However, con­
flicting results have been reported in the literature, ranging from a significant inverse association
between dairy consumption and the risk of developing type 2 DM6­10 to no significant associa­
tions.11–14 An Australian study run over five years found that dairy intake independently reduced
the risk of DM.6 In another long­term study (10 years), people with the highest intake of dairy had
a 59% lower risk of developing Metabolic Syndrome.10 Although the risk for DM was also lower in
this group, it was neither consistent nor significant. Other studies reported the intake of cheese
and fermented dairy products to be inversely associated with fasting plasma glucose and two­
hour post­prandial glucose values.11,12 Similarly, total dairy intake was not significantly associated
with the incidence of type 2 DM in the 10­year Whitehall II cohort study. Although an inverse as­
sociation was found between fermented dairy product intake and mortality, no such association
was observed with type 2 DM incidence.13
Association between the intake of dairy products and the risk of type 2 DM
Recent meta­analyses have reported consistent and significant evidence that the consumption of
dairy products reduces the risk of type 2 DM. High intake of dairy products in general was
associated with a significant reduction – between 11% and 15% – in the risk of type 2 DM7–9,14,15
and low­fat dairy consumption specifically was associated with a 10–19% lower risk of type 2
DM.7–9,15 The association appears to be independent of type of low­fat dairy product, as intakes of
low­fat milk, cheese, yoghurt and fermented dairy products were all associated with reducing the
risk of type 2 DM.7–9 In contrast, no significant association was found between the intake of full­fat 
dairy, total milk and full­fat milk7,8 and the risk of type 2 DM.
Dose–response association between dairy consumption and risk of type 2 DM
The best risk reduction was reported for total dairy intake up to 200 g per day, with the largest 
reduction associated with lower intakes.7,8 Although the association was still significant with higher 
intakes, risk reduction was more modest. No additional benefit was found with intakes exceeding 
300–400 g per day.8 For low-fat dairy, 300 g per day was reported to be associated with the best risk 
reduction.7 No additional benefit was found for intakes exceeding 400 g per day.7 Yoghurt intakes 
exceeding 120–140 g per day provided no further risk reduction.8
Possible mechanisms of action
The question can be asked whether the positive association found between dairy consumption
and reduced risk of DM could be due to the higher intake of protein and amino acids in general,
or whether it should be ascribed to the individual nutrient components of dairy.
Lower­fat dairy products produced stronger associations than full­fat dairy products, suggesting 
that dairy fat is not the only important nutrient to consider.16 For an intervention to be effective, it 
would need to address the risk factors resulting in the development of type 2 DM. Hence, mani­
pulating insulin receptor sensitivity, regulating insulin secretion and reducing insulin resistance 
could all be effective in targeting primary causes of DM. On the contrary, any changes in lifestyle­
associated risk factors (e.g. weight loss or prevention of weight gain, lower blood pressure, increased 
satiety) could be equally effective.2,17,18 Various mechanisms could therefore explain the inverse 
association between the intake of dairy products and the reduced risk of type 2 DM. 
Milk and dairy products have an abundance of calcium, magnesium and vitamin D*. The positive
effects of these nutrients include their role in increasing insulin receptor expression, improving
insulin sensitivity and beta cell function, decreasing fat absorption, increasing weight loss and
reducing blood pressure. Dairy consumption also aids in weight loss by means of increasing the
thermic effect of a meal and fat oxidation. Dairy protein, such as whey protein, is specifically
known to increase satiety and lower blood pressure pressure.7–9,14,17,19,20
The role of
dairy consumption
in preventing Type 2
Diabetes Mellitus
* Take note: South African milk is not fortifiedwith vitamin D
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